Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TNF | P01375 | 1/20 | 0.44 |
| ▸ | GPR34 | Q9UPC5 | 1/20 | 0.43 |
| ▸ | CTSL | P07711 | 1/20 | 0.43 |
| ▸ | CTSS | P25774 | 1/20 | 0.43 |
| ▸ | TACR1 | P25103 | 1/20 | 0.42 |
| ▸ | MRGPRX1 | Q96LB2 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | LAP3 | P28838 | 1/20 | 0.41 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.41 |
| ▸ | PPIA | P62937 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1624864 | 0.83 | FFAR1 (0.53) | FFAR1FFAR4GRM4LMNAGPR34 | |
| SCHEMBL18946054 | 0.82 | PDCD1 (0.49) | FFAR1GRM4TNF | |
| SCHEMBL29248543 | 0.82 | FFAR1 (0.50) | FFAR1FFAR4LMNATACR1MRGPRX1 | |
| SCHEMBL1745793 | 0.81 | ALDH1A1 (0.53) | LMNATACR1KMT2ASMN1; SMN2LTA4H | |
| SCHEMBL8804399 | 0.81 | ALDH1A1 (0.53) | LMNATACR1KMT2ASMN1; SMN2LTA4H | |
| SCHEMBL11472824 | 0.81 | ALDH1A1 (0.53) | LMNATACR1KMT2ASMN1; SMN2LTA4H | |
| Hydrochloric Acid SCHEMBL31652401 | 0.81 | KYNU (0.48) | LMNAKMT2ASMN1; SMN2LTA4HLAP3 | |
| Hydrochloric Acid SCHEMBL10886394 | 0.80 | ALDH1A1 (0.52) | LMNATACR1KMT2ASMN1; SMN2LTA4H | |
| SCHEMBL5549275 | 0.79 | FOLH1 (0.46) | FFAR1FFAR4LMNAGPR34TACR1 | |
| SCHEMBL18116486 | 0.78 | GRM4 (0.54) | GRM4TNFKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020151534-A1 | Antithrombotic compounds | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2002-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020151534-A1 | Antithrombotic compounds | SERPINC1, PF4, F2 | FFAR1 1827/4885FFAR4 1821/4885GRM4 2422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.